TetraGenetics harnesses the unique capabilities of the protozoa Tetrahymena thermophila to produce recombinant proteins for use in the discovery of novel antibody therapeutics targeting membrane proteins implicated in numerous human diseases. With our world-renowned science team, we are developing large molecule drugs for autoimmune diseases, pain, respiratory diseases, and oncology.